List view / Grid view

Variant Pharmaceuticals



Variant and L&F Research to advance development of VAR 200

18 December 2015 | By Victoria White

Variant says VAR 200 has potential for treating multiple indications associated with the damaging effects of cellular accumulation of cholesterol and lipids on the kidney, including focal segmental glomerulosclerosis...